Literature DB >> 9236437

Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding.

A H Danser1, C A van Kesteren, W A Bax, M Tavenier, F H Derkx, P R Saxena, M A Schalekamp.   

Abstract

BACKGROUND: A local renin-angiotensin system in the heart is often invoked to explain the beneficial effects of ACE inhibitors in heart failure. The heart, however, produces little or no renin under normal conditions. METHODS AND
RESULTS: We compared the cardiac tissue levels of renin-angiotensin system components in 10 potential heart donors who died of noncardiac disorders and 10 subjects with dilated cardiomyopathy (DCM) who underwent cardiac transplantation. Cardiac levels of renin and prorenin in DCM patients were higher than in the donors. The cardiac and plasma levels of renin in DCM were positively correlated, and extrapolation of the regression line to normal plasma levels yielded a tissue level close to that measured in the donor hearts. The cardiac tissue-to-plasma concentration (T/P) ratios for renin and prorenin were threefold the ratio for albumin, which indicates that the tissue levels were too high to be accounted for by admixture with blood and diffusion into the interstitial fluid. Cell membranes from porcine cardiac tissue bound porcine renin with high affinity. The T/P ratio for ACE, which is membrane bound, was fivefold the ratio for albumin. Cardiac angiotensinogen was lower in DCM patients than in the donors, and its T/P ratio was half that for albumin, which is compatible with substrate consumption by cardiac renin.
CONCLUSIONS: These data in patients with heart failure support the concept of local angiotensin production in the heart by renin that is taken up from the circulation. Membrane binding may be part of the uptake process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236437     DOI: 10.1161/01.cir.96.1.220

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

Review 1.  Early imaging in heart failure: exploring novel molecular targets.

Authors:  Jamshid Shirani; Jagat Narula; William C Eckelman; Navneet Narula; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

Review 2.  Cardiac fibrosis: potential therapeutic targets.

Authors:  Shuin Park; Ngoc B Nguyen; Arash Pezhouman; Reza Ardehali
Journal:  Transl Res       Date:  2019-03-09       Impact factor: 7.012

Review 3.  Aliskiren: the first direct renin inhibitor for hypertension.

Authors:  Anton H van den Meiracker; A H Jan Danser
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

Review 4.  Urinary markers of intrarenal renin-angiotensin system activity in vivo.

Authors:  Lodi C W Roksnoer; Koen Verdonk; Anton H van den Meiracker; Ewout J Hoorn; Robert Zietse; A H Jan Danser
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

5.  Effects of nicotine on cardiovascular remodeling in a mouse model of systemic hypertension.

Authors:  E Sage Colombo; Joshua Davis; Mehran Makvandi; Mario Aragon; Selita N Lucas; Michael L Paffett; Matthew J Campen
Journal:  Cardiovasc Toxicol       Date:  2013-12       Impact factor: 3.231

Review 6.  Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action.

Authors:  Stavros G Drakos; Abdallah G Kfoury; Craig H Selzman; Divya Ratan Verma; John N Nanas; Dean Y Li; Josef Stehlik
Journal:  Curr Opin Cardiol       Date:  2011-05       Impact factor: 2.161

Review 7.  Imaging the renin-angiotensin- aldosterone system in the heart.

Authors:  Jamshid Shirani; Maria L Loredo; William C Eckelman; Elaine M Jagoda; Vasken Dilsizian
Journal:  Curr Heart Fail Rep       Date:  2005-08

Review 8.  Is angiotensin II made inside or outside of the cell?

Authors:  Wenxia Chai; A H Jan Danser
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

9.  Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia.

Authors:  Hans Imboden; Jaspal Patil; Juerg Nussberger; Françoise Nicoud; Benno Hess; Nermin Ahmed; Thomas Schaffner; Maren Wellner; Dominik Müller; Tadashi Inagami; Takaaki Senbonmatsu; Jaroslav Pavel; Juan M Saavedra
Journal:  Regul Pept       Date:  2009-02-12

Review 10.  Cardiovascular effects of losartan and its relevant clinical application.

Authors:  Feichao Xu; Caiping Mao; Yali Hu; Can Rui; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.